ID18301A - Metode-metode untuk pencegahan proliferasi seluler dan restenosis - Google Patents

Metode-metode untuk pencegahan proliferasi seluler dan restenosis

Info

Publication number
ID18301A
ID18301A IDP972912A ID972912A ID18301A ID 18301 A ID18301 A ID 18301A ID P972912 A IDP972912 A ID P972912A ID 972912 A ID972912 A ID 972912A ID 18301 A ID18301 A ID 18301A
Authority
ID
Indonesia
Prior art keywords
restenosis
prevention
methods
cellular proliferation
proliferation
Prior art date
Application number
IDP972912A
Other languages
English (en)
Inventor
Margaret Forney Prescott
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID18301A publication Critical patent/ID18301A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11013—Protein kinase C (2.7.11.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP972912A 1996-08-20 1997-08-20 Metode-metode untuk pencegahan proliferasi seluler dan restenosis ID18301A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2421996P 1996-08-20 1996-08-20
US2507296P 1996-08-30 1996-08-30

Publications (1)

Publication Number Publication Date
ID18301A true ID18301A (id) 1998-02-26

Family

ID=26698189

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972912A ID18301A (id) 1996-08-20 1997-08-20 Metode-metode untuk pencegahan proliferasi seluler dan restenosis

Country Status (3)

Country Link
AU (1) AU4205597A (id)
ID (1) ID18301A (id)
WO (1) WO1998007415A2 (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190869B1 (en) 1999-10-26 2001-02-20 Isis Pharmaceuticals, Inc. Antisense inhibition of protein kinase C-theta expression
US6641611B2 (en) 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
CN1582150B (zh) * 2001-10-30 2011-09-07 诺瓦提斯公司 作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物
DE102004019413A1 (de) * 2004-04-19 2005-11-24 Phenos Gmbh Hemmung der Proteinkinase C epsilon zur Behandlung von Krankheiten
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
WO2008033956A2 (en) 2006-09-13 2008-03-20 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
EP0368223A3 (de) * 1988-11-10 1991-09-25 Hoechst Aktiengesellschaft Verwendung von Ethylendiamintetraessigsäure als Inhibitor der Calcium/Calmodulin abhängigen Proteinkinase II oder der Proteinkinase C
US5242397A (en) * 1989-06-20 1993-09-07 Cedars-Sinai Medical Center Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
AU675638B2 (en) * 1992-03-16 1997-02-13 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of protein kinase C
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives

Also Published As

Publication number Publication date
AU4205597A (en) 1998-03-06
WO1998007415A2 (en) 1998-02-26
WO1998007415A3 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
ID27589A (id) Pirimidina bisiklik dan dihidropirimidina bisiklik 3,4 sebagai penghambat proliferasi selular
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
BR9709811A (pt) Composto de indenonaftopiranos e artigo fotocrómico
BR9711799A (pt) Composto de indenonaftopiranos e artigo fotocr-mico
PT946323E (pt) Pos de niobio e condensadores eletroliticos de niobio
DE69836299D1 (de) Verfahren und Gerät zur Feldprüfung von zellularen Telefonen
DE69835514D1 (de) Mikrowellenantennensystem und verfahren
ID18128A (id) Metode dan peralatan untuk menyelaraskan sistim radio pribadi
EP0971723A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
DE69834401D1 (de) Businterfacesystem und verfahren
DE69840301D1 (de) Verfahren und system zur ortsbestimmung von mobilfunkendgeräten
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
ID19422A (id) Piridina dan bifenil tersubstitusi
PL340606A1 (en) Methods of and materials for treating and preventing mucositis
EP1018987A4 (en) NEO-CARTILAGE AND ITS METHODS OF USE
MA26668A1 (fr) ACTIVATEURS DE hPPARy ET hPPARa
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
DE69838230D1 (de) Frequenzumsetzer und verfahren
ID21332A (id) Metode dan komposisi untuk pengobatan dan pencegahan hiperurikemia
PT927183E (pt) Inibidores espirociclicos de metaloproteases
ID19385A (id) Adesif termosetting dan metoda pembuatannya
PL336582A1 (en) Leptin as an inhibitor of neoplastic cell proliferation
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
DE19782204T1 (de) Verlängerungseinrichtung und Verfahren
FI964550A0 (fi) Taajuushyppelymenetelmä ja radiojärjestelmä